Question 1

Nitroglycerin sublingual tablets are exempt from child-resistant packaging.

Nitroglycerin sublingual tablets are specifically designed for the rapid treatment of angina and are exempt from child-resistant packaging requirements due to their critical medical use and the need for immediate access in emergency situations.

A) Methotrexate tablets

Methotrexate tablets are not exempt from child-resistant packaging as they are associated with severe risks if ingested by children. Methotrexate is a chemotherapy agent and can cause significant harm, thus necessitating child-resistant packaging to prevent accidental ingestion.

B) HCTZ tablets

HCTZ (hydrochlorothiazide) tablets are also not exempt from child-resistant packaging. While they are used to treat high blood pressure, they can have adverse effects if consumed by children, making child-resistant packaging a necessary precaution.

C) Nitroglycerin sublingual tablets

Nitroglycerin sublingual tablets are exempt from child-resistant packaging due to their urgent therapeutic role in managing angina. This exemption allows for quick access during a medical emergency, where time is critical.

D) Isosorbide mononitrate

Isosorbide mononitrate is not exempt from child-resistant packaging. Similar to other cardiovascular medications, it poses risks if ingested by children, thus requiring child-resistant measures to mitigate potential hazards.

Conclusion

Nitroglycerin sublingual tablets are the only option among the choices provided that is exempt from child-resistant packaging, primarily due to their essential role in emergency medical treatment. The other options, including methotrexate, HCTZ, and isosorbide mononitrate, all require child-resistant packaging to protect against the risks they pose to children.